NIH-funded research NIH-funded research

Medications to treat sleep apnea and boost thinking in children with Down syndrome

Official title: Medications for Obstructive Sleep Apnea to Improve Cognition in Children with Down Syndrome (MOSAIC DS)

Funded at University of Arizona · NIH-11178895 · Data updated 2026-11-12

This project gives a combination of two commonly used medicines, atomoxetine and oxybutynin, to children with Down syndrome who have obstructive sleep apnea to see if it helps them sleep better and think more clearly.

More Cognition research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Arizona
NIH-funded
Lab location1 site (Tucson, United States)
Project startSeptember 15, 2019
Project endAugust 31, 2026
Funding year2025
Award (this year)$297,765
NIH project number3R33HL151254-05S1
Project IDNIH-11178895 on NIH RePORTER

Who could benefit from this research

Could help

Children with Down syndrome who have diagnosed obstructive sleep apnea and whose caregivers are willing to try nightly medication and attend study visits are the ideal candidates.

Less likely to help

Children without obstructive sleep apnea, those with medical reasons they cannot take atomoxetine or oxybutynin, or those who cannot adhere to nightly medication may not benefit from this approach.

What this research studies

Your child would receive a nightly combination of atomoxetine and oxybutynin, two drugs already used in children for other conditions. The study team will use overnight sleep studies and other sleep measures to track changes in breathing during sleep and will use brief cognitive tests and questionnaires to track thinking, behavior, and quality of life. Doctors will monitor for side effects and how well families can give the medicine each night. The aim is to offer a non-surgical, medication-based option that could reduce sleep apnea and its impact on learning and daily life.

Why it matters

Potential benefit: If successful, this treatment could reduce sleep apnea symptoms and improve thinking, behavior, and overall quality of life for children with Down syndrome.

How similar studies have gone: The drug combination has helped adults with OSA and nerve-stimulation surgery has helped some adolescents with Down syndrome, but medication use for sleep apnea in young children with Down syndrome is relatively novel.

Where this research is happening

  • University of Arizona
    Tucson, United States
    Active

Researchers

  • Principal investigator: Combs, Daniel — University of Arizona
  • Study coordinator: Combs, Daniel

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.